207 related articles for article (PubMed ID: 34973472)
1. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment.
Wadayama T; Shimizu M; Yata T; Ishikura T; Kajiyama Y; Hirozawa D; Okuno T; Mochizuki H
J Neuroimmunol; 2022 Feb; 363():577789. PubMed ID: 34973472
[TBL] [Abstract][Full Text] [Related]
2. Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
Cantarín-Extremera V; Jiménez-Legido M; Duat-Rodríguez A; García-Fernández M; Ortiz-Cabrera NV; Ruiz-Falcó-Rojas ML; González-Gutiérrez-Solana L
J Neuroimmunol; 2020 Mar; 340():577142. PubMed ID: 31935626
[TBL] [Abstract][Full Text] [Related]
3. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab treatment for new onset refractory status epilepticus.
Jun JS; Lee ST; Kim R; Chu K; Lee SK
Ann Neurol; 2018 Dec; 84(6):940-945. PubMed ID: 30408233
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cryptogenic new-onset refractory status epilepticus (C-NORSE) with tocilizumab: A case report.
Nakamura Y; Ueda M; Kodama S; Kimura T; Shirota Y; Hamada M; Ishiura H; Iizuka T; Toda T
Intern Med; 2024 Apr; ():. PubMed ID: 38658340
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of potassium bromide in the treatment of drug-resistant epilepsy: a case of new-onset refractory status epilepticus].
Takei J; Takei R; Nozuma S; Nakahara K; Watanabe O; Takashima H
Rinsho Shinkeigaku; 2016 Nov; 56(11):759-763. PubMed ID: 27773903
[TBL] [Abstract][Full Text] [Related]
7. [A case of cryptogenic new-onset refractory status epilepticus (NORSE) in which cerebrospinal fluid IL-6 was elevated with increased seizure frequency early in the disease: a case report].
Nakada R; Terasawa Y; Sato T; Takatsu H; Kaito N; Iguchi Y
Rinsho Shinkeigaku; 2023 Dec; 63(12):843-846. PubMed ID: 37989289
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes among initial survivors of cryptogenic new-onset refractory status epilepsy (NORSE).
Costello DJ; Matthews E; Aurangzeb S; Doran E; Stack J; Wesselingh R; Dugan P; Choi H; Depondt C; Devinsky O; Doherty C; Kwan P; Monif M; O'Brien TJ; Sen A; Gaspard N
Epilepsia; 2024 Jun; 65(6):1581-1588. PubMed ID: 38498313
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of New-Onset Refractory Status Epilepticus (NORSE).
Hanin A; Cespedes J; Huttner A; Strelnikov D; Gopaul M; DiStasio M; Vezzani A; Hirsch LJ; Aronica E
J Neurol; 2023 Aug; 270(8):3688-3702. PubMed ID: 37079033
[TBL] [Abstract][Full Text] [Related]
10. High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE).
Aydemir S; Kandula P
Seizure; 2022 Jan; 94():126-128. PubMed ID: 34896815
[No Abstract] [Full Text] [Related]
11. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
[TBL] [Abstract][Full Text] [Related]
12. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
[TBL] [Abstract][Full Text] [Related]
13. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
[TBL] [Abstract][Full Text] [Related]
14. Time to FIRE NORSE: A single acronym for a heterogeneous presentation. Further information from a case series and discussion of the literature.
Alaskar AM; Aljohani MA; Dionisio S; Asiry MA; Alqadi K
J Neuroimmunol; 2024 Mar; 388():578298. PubMed ID: 38330780
[TBL] [Abstract][Full Text] [Related]
15. Severe, Refractory Seizures: New-Onset Refractory Status Epilepticus and Febrile Infection-Related Epilepsy Syndrome.
Carson R; Stredny CM
Med Clin North Am; 2024 Jan; 108(1):201-213. PubMed ID: 37951651
[TBL] [Abstract][Full Text] [Related]
16. The Increased Interleukin-6 Levels Can Be an Early Diagnostic Marker for New-Onset Refractory Status Epilepticus.
Kwack DW; Kim DW
J Epilepsy Res; 2022 Dec; 12(2):78-81. PubMed ID: 36685741
[TBL] [Abstract][Full Text] [Related]
17. Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?
Costello DJ; Kilbride RD; Cole AJ
J Neurol Sci; 2009 Feb; 277(1-2):26-31. PubMed ID: 19013586
[TBL] [Abstract][Full Text] [Related]
18. Treatment of COVID-19-induced refractory status epilepticus by tocilizumab.
Kizilkilic EK; Unkun R; Uygunoglu U; Delil S; Ozkara C
Eur J Neurol; 2022 Sep; 29(9):2861-2863. PubMed ID: 35678591
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of subsequent extra-temporal involvement in cryptogenic new onset refractory status epilepticus (NORSE) initially diagnosed with limbic encephalitis.
Choi JY; Kim EJ; Moon SY; Kim TJ; Huh K
Epilepsy Res; 2019 Dec; 158():106215. PubMed ID: 31669912
[TBL] [Abstract][Full Text] [Related]
20. Multi-proteomic Analysis Revealed Distinct Protein Profiles in Cerebrospinal Fluid of Patients Between Anti-NMDAR Encephalitis NORSE and Cryptogenic NORSE.
Wang D; Wu Y; Pan Y; Wang S; Liu G; Gao Y; Xu K
Mol Neurobiol; 2023 Jan; 60(1):98-115. PubMed ID: 36224320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
